I 

109TH CONGRESS 

1ST SESSION H. R. 3550 

To amend the Public Health Service Act to improve provisions relating to 

Parkinson’s disease research. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 28, 2005 

Mr. EVANS (for himself, Mrs. MALONEY, Mr. UDALL of Colorado, and Mr. 

BOEHLERT) introduced the following bill; which was referred to the Committee on Energy and Commerce 

A BILL 

To amend the Public Health Service Act to improve 

provisions relating to Parkinson’s disease research. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Morris K. Udall Par5 kinson’s Disease Research Act Amendments of 2005’’. 

6 SEC. 2. MORRIS K. UDALL PARKINSON’S DISEASE RE7 SEARCH ACT OF 1997. 

8 (a) FINDINGS.—Subsection (b) of section 603 of the 

9 Morris K. Udall Parkinson’s Disease Research Act of 

10 1997 (42 U.S.C. 284f note) is amended— 
2 

•HR 3550 IH 

1 (1) in the subsection heading by striking 

2 ‘‘FINDING’’and inserting ‘‘FINDINGS’’; and 

3 (2) by striking paragraph (1) and inserting the 

4 following: 

5 ‘‘(1) FINDINGS.—Congress finds the following: 

6 ‘‘(A) To take full advantage of the tremen7 dous potential for finding a cure or effective 

8 treatment, the Federal investment in Parkin9 son’s must be expanded, as well as the coordi10 nation strengthened among the National Insti11 tutes of Health research institutes. 

12 ‘‘(B) The National Institutes of Health 

13 should invest in national health priorities focus14 ing on those with the greatest expense to soci15 ety or research with positive, translational, and 

16 measurable outcomes. Parkinson’s research, 

17 with its clear potential for translating basic re18 search into clinical results applicable to a wide 

19 array of disorders, is a prime example of re20 search that fulfills the National Institutes of 

21 Health’s national health priority criteria, in22 cluding the high expense to society.’’. 

23 (b) PUBLIC HEALTH SERVICE ACT.—Section 409B 

24 of the Public Health Service Act (42 U.S.C. 284f) is 

25 amended— 
3 

•HR 3550 IH 

1 (1) in subsection (b), by striking paragraph (2) 

2 and inserting the following: 

3 ‘‘(2) CONFERENCE.— 

4 ‘‘(A) IN GENERAL.—The Director of NIH 

5 shall convene a coordinating and planning con6 ference every 2 years with relevant institutes 

7 and non-governmental organizations to conduct 

8 a thorough investigation of all Parkinson’s re9 search that is funded in whole or in part by the 

10 National Institutes of Health and to identify 

11 shortcomings and opportunities for more effec12 tive treatments and a cure for Parkinson’s dis13 ease. The Director shall report to Congress on 

14 the coordination among the institutes in car15 rying out such research. 

16 ‘‘(B) RESEARCH INVESTMENT PLAN.— 

17 ‘‘(i) IN GENERAL.—The results of 

18 each conference convened under subpara19 graph (A) shall be included in a research 

20 investment plan that provides for measur21 able results with the goals of better treat22 ments and a cure for Parkinson’s disease 

23 being the determining factors in the alloca24 tion of Parkinson’s disease research dol25 lars. The plan shall include an outline of 
4 

•HR 3550 IH 

1 the manner in which to fully utilize the 

2 Udall Center program to ensure the con3 tinuation of a particular focus on 

4 translational research, including a clinical 

5 component. 

6 ‘‘(ii) BUDGET AND IMPLEMENTATION

7 STRATEGY.—The plan submitted under 

8 clause (i) shall include a budget (that in9 cludes both programmatic and dollar line 

10 items) and implementation strategy (that 

11 incorporates the use of special initiatives 

12 such as requests for applications, program 

13 announcements with set-asides, or similar 

14 directed research mechanisms) together 

15 with results to be reported back to Con16 gress. 

17 ‘‘(C) SUBMISSIONS TO CONGRESS.—The 

18 plan under subparagraph (B) (including the 

19 budget and implementation strategy) and the 

20 expected results of plan implementation shall be 

21 submitted to Congress not later than 3 months 

22 after the conference is convened under subpara23 graph (A). Reports on the outcomes of the plan, 

24 including actual spending and actual results, 
5 

•HR 3550 IH 

1 shall be submitted to Congress on an annual 

2 basis. 

3 ‘‘(D) FUNDING.—The Secretary shall en4 sure that adequate funding is available under 

5 this section to carry out the activities described 

6 in the investment plan under subparagraph 

7 (B).’’; 

8 (2) in subsection (c)— 

9 (A) in paragraph (1)— 

10 (i) by striking ‘‘not more than 10’’; 

11 and 

12 (ii) by adding at the end the fol13 lowing: ‘‘The Director shall ensure that an 

14 additional center shall be funded under 

15 this paragraph to serve as the coordinating 

16 center to coordinate the activities con17 ducted by each of the centers funded under 

18 this paragraph to further focus and man19 age the interdisciplinary efforts of such 

20 centers.’’; 

21 (B) in paragraph (2)(A)(ii), by striking 

22 ‘‘conduct basic and clinical research’’ and in23 serting ‘‘in carrying out research, ensure that a 

24 significant clinical component is provided for in 

25 addition to ongoing basic research’’; and 
6 

•HR 3550 IH 

1 (C) by adding at the end the following: 

2 ‘‘(5) REVIEW PROCESS.—The Director of NIH 

3 shall establish a review process with respect to appli4 cations received for grants under paragraph (1). 

5 Such process shall provide for the evaluation of ap6 plicants in a manner that recognizes the unique as7 pects of the clinical, coordination, and multidisci8 plinary components of the applicants.’’; 

9 (3) in subsection (d)— 

10 (A) by striking ‘‘is authorized to establish 

11 a grant program’’ and inserting ‘‘shall award 

12 grants’’; and 

13 (B) by inserting before the period at the 

14 end the following: ‘‘and shall be awarded in a 

15 manner consistent with the research investment 

16 plan under subsection (b)(2)(B)’’; and 

17 (4) by striking subsection (e) and inserting the 

18 following: 

19 ‘‘(e) REPORT.—The Director of NIH, in consultation 

20 with the Director of the Centers for Disease Control and 

21 Prevention, shall conduct an investigation, and prepare 

22 and submit to the appropriate committees of Congress a 

23 report, on the incidence of Parkinson’s disease, including 

24 age, occupation, and geographic population clusters, and 

25 related environmental factors relating to such disease. 
7 

•HR 3550 IH 

1 ‘‘(f) AUTHORIZATION OF APPROPRIATIONS.— For 

2 the purpose of carrying out this section, and section 301 

3 and this title with respect to research focused on Parkin4 son’s disease, there are authorized to be appropriated up 

5 to $100,000,000 for fiscal year 1998, such sums as may 

6 be necessary for each of the fiscal years 1999 and 2000, 

7 and such sums as may be necessary for fiscal years 2006 

8 and each subsequent fiscal year.’’. 

Æ